Cerevel Therapeutics
Biotech · Acquired
Small molecule therapeutics targeting dopamine D1 receptors and muscarinic receptors for neuropsychiatric disorders
cereveltherapeutics.com →- Grants
- $11M
- 3 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 15
- 0 granted · 15 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20212022
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant· 1 of 3 same day | Department of Health and Human Services · UH3 · CVL-354, a kappa opioid receptor antagonist for treatment of opioid use disorder, withdrawal and relapse | $2,700,000 | |
| Federal grant· 2 of 3 same day | Department of Health and Human Services · UH3 · CVL-354, a kappa opioid receptor antagonist for treatment of opioid use disorder, withdrawal and relapse | $2,700,000 | |
| Federal grant· 3 of 3 same day | Department of Health and Human Services · UG3 · CVL-354, a kappa opioid receptor antagonist for treatment of opioid use disorder, withdrawal and relapse | $5,400,000 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2489 | APPLIED GENETIC TECHNOLOGIES CORPORATION | — | $9.3M |
| 2490 | 3+2 PHARMA, LLC | — | — |
| 2491 | CELL DATA SCIENCES, INC. | — | — |
| 2492 | Cerevel Therapeutics | — | — |
| 2493 | BIOMARCK PHARMACEUTICALS, LTD | — | $8.0M |
| 2494 | AMYGDALA NEUROSCIENCES, INC. | — | $7.0M |
| 2495 | Cirrus Therapeutics, Inc. | — | $6.7M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Solid Oral Dosage Forms Comprising Tavapadonapplication
- M4 Activators/modulators And Uses Thereofapplication
- Use Of Tavapadon In Treating Parkinson's Diseaseapplication
- Use Of Tavapadon In Treating Parkinson's Diseaseapplication
- Solid Oral Dosage Forms Comprising Tavapadonapplication
- Use Of Tavapadon In Treating Parkinson's Diseaseapplication
- M4 Activators/modulators And Uses Thereofapplication
- Azaindole Compounds And Their Use As Phosphodiesterase Inhibitorsapplication
- M4 Activators/modulators And Uses Thereofapplication
- M4 Activators/Modulators and Uses Thereofapplication
- M4 Activators/modulators And Uses Thereofapplication
- Spiro Derivatives As M4 Activators/modulators And Uses Thereofapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.